oculotect fluid
ciba vision australia pty ltd (nz) - povidone 50 mg/ml - eye drops, solution - 50 mg/ml - active: povidone 50 mg/ml excipient: benzalkonium chloride boric acid calcium chloride dihydrate magnesium chloride hexahydrate potassium chloride sodium chloride sodium lactate water
oculotect fluid sine
ciba vision australia pty ltd (nz) - povidone 50 mg/ml - eye drops, solution - 50 mg/ml - active: povidone 50 mg/ml excipient: boric acid calcium chloride dihydrate magnesium chloride hexahydrate potassium chloride purified water sodium chloride sodium lactate
interceptor tab 5.75mg tablet
ciba-geigy canada ltd, animal health division - milbemycin oxime - tablet - 5.75mg - milbemycin oxime 5.75mg - dog or cat
interceptor tab 11.5mg tablet
ciba-geigy canada ltd, animal health division - milbemycin oxime - tablet - 11.5mg - milbemycin oxime 11.5mg - dog or cat
interceptor tab 23mg tablet
ciba-geigy canada ltd, animal health division - milbemycin oxime - tablet - 23mg - milbemycin oxime 23mg - dog or cat
interceptor tab 2.3mg tablet
ciba-geigy canada ltd, animal health division - milbemycin oxime - tablet - 2.3mg - milbemycin oxime 2.3mg - dog or cat
equipoise injectable 50mg/ml liquid
ciba-geigy canada ltd, animal health division - boldenone undecylenate - liquid - 50mg - boldenone undecylenate 50mg - horses
interceptor chewable tab 23mg tablet
ciba-geigy canada ltd, animal health division - milbemycin oxime - tablet - 23mg - milbemycin oxime 23mg - dogs
diclofenac sodium- diclofenac sodium solution
falcon pharmaceuticals, ltd. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - solution - 1 mg in 1 ml - diclofenac sodium ophthalmic solution, 0.1% is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction. diclofenac sodium ophthalmic solution, 0.1% is contraindicated in patients who are hypersensitive to any component of the medication.
vasocon- naphazoline hydrochloride solution
ciba vision - naphazoline hydrochloride (unii: mz1131787d) (naphazoline - unii:h231gf11bv) - solution - 1 mg in 1 ml - vaso con regular is indicated for use as a topical ocular vasoconstrictor. contraindicated in the presence of an anatomically narrow angle or in narrow angle glaucoma or in persons who have shown hypersensitivity to any component of this preparation.